Entrepreneurs: Astellas wants to help you launch your dream!
AXONIS Therapeutics were honored to be chosen as winner of Astellas Pharma Golden Ticket competition, which was an important validation of our therapeutic programs at that time. Since then we have tremendously benefitted from insightful discussions with the Astellas Pharma team and venture arm who kindly devoted their time to review our milestones/data and provided clear feedback on our plans. Access to LabCentral has equipped us with the perfect platform to establish our in vitro assays, and to continue to participate in this thriving biotech ecosystem.
Dr. Joanna Stanicka, CEO of AXONIS Therapeutics.
FREQUENTLY ASKED QUESTIONS
What is the Prize?
Winners will receive one year’s free space for an individual bench at the state-of-the-art lab facilities, along with all resident benefits. They will also gain access to Astellas’ R&D capabilities, business leaders, mentors and global network of partner academic institutes and biotechnology companies.
Who should apply?
Entrepreneurial scientists, emerging life science companies and biotechnology startups that are developing pioneering scientific research or building novel therapeutic programs, modalities or programs.
Will my science idea be a fit?
Astellas is interested in most all areas where scientific innovation is flourishing to create new medicines. This includes new drug discovery biologies, novel drug modalities and unique technology platforms across oncology, immunology/allergy, neuromuscular disorders, sensory disorders and neuroscience. Fields of particular focus include regenerative medicine, genetic regulation, mitochondrial biology and immuno-oncology. Our interests span a range of drug modalities including cell therapy, gene therapy, vaccines, small molecules, antibodies and targeted drug delivery systems.
Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs by focusing on Biology and Modality. Through these efforts, Astellas stands on the forefront of healthcare change to turn innovative science into VALUE for patients. For more information, please visit our website at https://www.astellas.com/en
FOR QUESTIONS, PLEASE CONTACT
Astellas Venture Management LLC
2000 Sierra Point Pkwy, Suite 500,
Brisbane, CA 94005
© Astellas Pharma Inc.